Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A delicate balance: role of MMP-9 in brain development and pathophysiology of neurodevelopmental disorders.
Metaboreflex activity in multiple sclerosis patients.
Neuron-macrophage crosstalk in the intestine: a "microglia" perspective.
Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases.
[Phenotypes of Charcot-Marie-Tooth Syndrome and Differential Diagnosis Focused in Inflammatory Neuropathies].
Feasibility and reproducibility of whole brain myelin water mapping in 4 minutes using fast acquisition with spiral trajectory and adiabatic T2prep (FAST-T2) at 3T.
Suppression of Locomotor Activity in Female C57Bl/6J Mice Treated with Interleukin-1β: Investigating a Method for the Study of Fatigue in Laboratory Animals.
Cucurbitacins attenuate microglial activation and protect from neuroinflammatory injury through Nrf2/ARE activation and STAT/NF-κB inhibition.
[Guillain-Barré syndrome in infancy: The importance of electroneuromyography].
Cesarean delivery may increase the risk of multiple sclerosis.
Interference of upper limb tremor on daily life activities in people with multiple sclerosis.
Growth hormone response to clonidine administration for evaluation of autonomic dysfunction in multiple sclerosis patients.
Relative contribution of cognitive and physical disability components to quality of life in MS.
Calreticulin and other components of endoplasmic reticulum stress in rat and human inflammatory demyelination.
[The impact of the vitamin D in neurological diseases and neurorehabilitation: from demencia to multiple sclerosis. Part I: the role of the vitamin D in the prevetion and treatment of multiple sclerosis].
Ischemia modified albumin is an indicator of oxidative stress in multiple sclerosis.
Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination.
Monoclonal antibody therapy in multiple sclerosis: critical appraisal and new perspectives.
[Extending therapeutic possibilities in relapsing-remitting multiple sclerosis: dimethyl fumarate].
The Neurocognitive Profile of the Cerebellum in Multiple Sclerosis.
Neurourologic dysfunction: evaluation, surveillance and therapy.
Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing-remitting multiple sclerosis.
Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple Sclerosis.
The UK Risk-Sharing Scheme for interferon-beta and glatiramer acetate in multiple sclerosis. Outcome of the year-6 analysis.
Correction: Increased Perfusion in Normal Appearing White Matter in High Inflammatory Multiple Sclerosis Patients.

Pages